Sep 2, 2026 07:04AM

Aug 19, 2026 08:32PM

Aug 5, 2026 07:00AM

Jul 30, 2026 06:37PM

Jul 21, 2026 05:00PM

Jul 21, 2026 05:00PM

Jul 20, 2026 07:41PM Telix Pharmaceuticals posts $247M in Q2 revenue, raises R&D outlook

Jul 20, 2026 07:31PM

Jul 20, 2026 05:00PM

Jul 20, 2026 05:00PM

Jul 15, 2026 04:20PM

Jul 7, 2026 07:03AM

Jul 1, 2026 09:31PM

Jul 1, 2026 09:31PM FDA Alignment to Advance ProstACT Global Phase 3 Trial

Jun 2, 2026 07:01AM

Jun 2, 2026 07:00AM

Jun 1, 2026 05:00PM

Jun 1, 2026 05:00PM

Jun 1, 2026 12:55AM

May 15, 2026 06:31AM

May 15, 2026 06:30AM Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

Apr 14, 2026 07:05PM

Apr 14, 2026 07:04PM

Apr 10, 2026 06:45AM

Apr 10, 2026 05:30AM

Apr 9, 2026 06:51PM

Apr 6, 2026 07:37PM

Mar 15, 2026 05:25PM Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

Mar 9, 2026 07:20PM

Mar 9, 2026 07:19PM

Feb 27, 2026 07:00AM

Feb 19, 2026 07:02PM

Feb 17, 2026 04:57PM

Feb 17, 2026 04:55PM

Jan 20, 2026 07:00AM Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch

Jan 16, 2026 02:20PM

Jan 16, 2026 02:19PM

Dec 21, 2025 04:38PM

Dec 21, 2025 04:38PM

Dec 10, 2025 07:00AM

Dec 10, 2025 07:00AM

Nov 19, 2025 02:00PM ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

Oct 23, 2025 07:03AM

Oct 23, 2025 07:00AM

Oct 14, 2025 02:22AM

Sep 23, 2025 10:15AM

Sep 23, 2025 10:15AM

Sep 9, 2025 07:00PM

Sep 9, 2025 07:00PM Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis

Jul 22, 2025 04:06AM

330,115 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All